加拿大药物保险计划：回顾与展望。
Canadian pharmacare: looking back, looking forward.
作者信息
Morgan Steven G, Daw Jamie R
机构信息
Associate Professor and Associate Director, Centre for Health Services and Policy Research, School of Population and Public Health, University of British Columbia, Vancouver, BC.
出版信息
Healthc Policy. 2012 Aug;8(1):14-23.
Abstract
Despite Canadians' pride in medicare and the values underpinning it, the system is conspicuously incomplete. Universal public health insurance in Canada ends as soon as a patient is handed a prescription to fill; yet prescription drugs are the second largest component of health system costs. We look back at key moments in Canadian healthcare history that shaped our pharmacare system - or lack thereof. We look forward to changes in demography and technology that will increase the need for pharmacare reform in the near future. We conclude that meaningful public engagement in pharmacare design may generate the clarity of goals and level of political support needed should windows of policy opportunity open again.
摘要
尽管加拿大人对医疗保险及其所秉持的价值观深感自豪，但该体系明显并不完善。在加拿大，一旦患者拿到处方去配药，全民公共医疗保险就终止了；然而处方药却是医疗系统成本的第二大组成部分。我们回顾了加拿大医疗保健历史上塑造我们的药物护理体系（或缺乏该体系）的关键时刻。我们展望人口结构和技术方面的变化，这些变化将在不久的将来增加药物护理改革的必要性。我们得出结论，公众有意义地参与药物护理设计，可能会在政策机遇之窗再次开启时，产生所需的目标清晰度和政治支持力度。
相似文献
1
Canadian pharmacare: looking back, looking forward.加拿大药物保险计划：回顾与展望。
Healthc Policy. 2012 Aug;8(1):14-23.
2
Universal Pharmacare in Canada: A Prescription for Equity in Healthcare.加拿大全民医保：医疗保健公平的一剂良药。
Int J Health Policy Manag. 2020 Mar 1;9(3):91-95. doi: 10.15171/ijhpm.2019.93.
3
Federal budget disappoints on universal pharmacare.联邦预算在全民药物保险方面令人失望。
CMAJ. 2019 Apr 8;191(14):E406-E407. doi: 10.1503/cmaj.109-5736.
4
Estimated effects of adding universal public coverage of an essential medicines list to existing public drug plans in Canada.在加拿大现有公共药品计划中增加基本药物清单的全民公共覆盖的估计效果。
CMAJ. 2017 Feb 27;189(8):E295-E302. doi: 10.1503/cmaj.161082.
5
It Won't Be Easy: How to Make Universal Pharmacare Work in Canada.实现全民医保并不容易：加拿大的经验。
Int J Health Policy Manag. 2020 Jan 1;9(1):1-5. doi: 10.15171/ijhpm.2019.82.
6
Universal prescription drug coverage in Canada: Long-promised yet undelivered.加拿大全民处方药保险：承诺已久却未实现。
Healthc Manage Forum. 2016 Nov;29(6):247-254. doi: 10.1177/0840470416658907. Epub 2016 Oct 15.
7
Stitching the gaps in the Canadian public drug coverage patchwork?: a review of provincial pharmacare policy changes from 2000 to 2010.填补加拿大公共药物覆盖拼图上的空白？：2000 年至 2010 年省级药物保险政策变化的回顾。
Health Policy. 2012 Jan;104(1):19-26. doi: 10.1016/j.healthpol.2011.08.015. Epub 2011 Oct 5.
8
National Pharmacare in Canada: Equality or Equity, Accessibility or Affordability Comment on "Universal Pharmacare in Canada: A Prescription for Equity in Healthcare".加拿大的国家药物福利计划：平等还是公平，可及性还是可负担性 评“加拿大全民药物福利计划：医疗保健公平的处方”。
Int J Health Policy Manag. 2020 Dec 1;9(12):524-527. doi: 10.15171/ijhpm.2019.146.
9
Should national pharmacare apply a value-based insurance design?国家药物保险计划是否应采用基于价值的保险设计？
CMAJ. 2019 Jul 22;191(29):E811-E815. doi: 10.1503/cmaj.181721.
10
Distributional consequences of the transition from age-based to income-based prescription drug coverage in British Columbia, Canada.加拿大不列颠哥伦比亚省从基于年龄的处方药保险向基于收入的处方药保险过渡的分配后果。
Health Econ. 2008 Dec;17(12):1379-92. doi: 10.1002/hec.1337.
引用本文的文献
1
Acceptability of a short list of essential medicines to patients and prescribers: Multimethod study.基本药物短名单对患者和处方者的可接受性：多方法研究。
Can Fam Physician. 2022 Jul;68(7):e204-e214. doi: 10.46747/cfp.6807e204.
2
After More Than 50 Years, Pharmacare (and Dental Care) are Coming to Canada.五十多年后，加拿大将迎来医药保健（和牙科保健）。
Int J Health Serv. 2022 Jul;52(3):341-346. doi: 10.1177/00207314221100654. Epub 2022 May 9.
3
Pharmaceutical policies: effects of regulating drug insurance schemes.药品政策：规范药品保险计划的影响
Cochrane Database Syst Rev. 2022 May 3;5(5):CD011703. doi: 10.1002/14651858.CD011703.pub2.
4
It Won't Be Easy: How to Make Universal Pharmacare Work in Canada.实现全民医保并不容易：加拿大的经验。
Int J Health Policy Manag. 2020 Jan 1;9(1):1-5. doi: 10.15171/ijhpm.2019.82.
5
Should national pharmacare apply a value-based insurance design?国家药物保险计划是否应采用基于价值的保险设计？
CMAJ. 2019 Jul 22;191(29):E811-E815. doi: 10.1503/cmaj.181721.
6
Changes in employer-sponsored private health insurance among retirees in Ontario: a cross-sectional study.安大略省退休人员中雇主赞助的私人医疗保险的变化：一项横断面研究。
CMAJ Open. 2019 Jan 21;7(1):E15-E22. doi: 10.9778/cmajo.20180067. Print 2019 Jan-Mar.
7
Community members co-designing a trial of medication access.共同设计药物获取试验的社区成员。
CMAJ. 2018 Nov 7;190(Suppl):S44-S45. doi: 10.1503/cmaj.180415.
8
Evaluating the effects of Quebec's private-public drug insurance system.评估魁北克公私合营药品保险制度的效果。
CMAJ. 2017 Oct 10;189(40):E1259-E1263. doi: 10.1503/cmaj.170726.
9
Medication access via hospital admission.通过住院获取药物治疗。
Can Fam Physician. 2017 May;63(5):344-347.
10
Introduction to the Special Issue: Precarious Solidarity-Preferential Access in Canadian Health Care.特刊引言：加拿大医疗保健中的不稳定团结与优先获得权
Health Care Anal. 2017 Jun;25(2):107-113. doi: 10.1007/s10728-016-0338-y.
本文引用的文献
1
Purchasing prescription drugs in Canada: hang together or hang separately.在加拿大购买处方药：团结还是分裂。
Healthc Policy. 2011 May;6(4):22-6.
2
Ivacaftor.依伐卡托
Nat Rev Drug Discov. 2012 Apr 30;11(5):349-50. doi: 10.1038/nrd3723.
3
The effect of cost on adherence to prescription medications in Canada.加拿大的药物依从性受成本因素的影响。
CMAJ. 2012 Feb 21;184(3):297-302. doi: 10.1503/cmaj.111270. Epub 2012 Jan 16.
4
Financial burden of household out-of-pocket expenditures for prescription drugs: cross-sectional analysis based on national survey data.家庭自费购买处方药的经济负担：基于全国调查数据的横断面分析
Open Med. 2011;5(1):e1-9. Epub 2011 Jan 4.
5
Stitching the gaps in the Canadian public drug coverage patchwork?: a review of provincial pharmacare policy changes from 2000 to 2010.填补加拿大公共药物覆盖拼图上的空白？：2000 年至 2010 年省级药物保险政策变化的回顾。
Health Policy. 2012 Jan;104(1):19-26. doi: 10.1016/j.healthpol.2011.08.015. Epub 2011 Oct 5.
6
The U.S. health system in perspective: a comparison of twelve industrialized nations.透视美国医疗体系：与十二个工业化国家的比较
Issue Brief (Commonw Fund). 2011 Jul;16:1-14.
7
The effect of evidence-based drug coverage policies on pharmaceutical r&d: a case study from british columbia.循证药物覆盖政策对药物研发的影响：来自不列颠哥伦比亚省的案例研究
Healthc Policy. 2008 Feb;3(3):54-63.
8
The effect of pharmaceutical patent term length on research and development and drug expenditures in Canada.药品专利期限对加拿大研发及药品支出的影响。
Healthc Policy. 2007 Feb;2(3):63-84.
9
Income-based drug coverage in british columbia: towards an understanding of the policy.不列颠哥伦比亚省基于收入的药物保险：对该政策的理解
Healthc Policy. 2006 Nov;2(2):92-108.
10
Chronic catastrophes: exploring the concentration and sustained nature of ambulatory prescription drug expenditures in the population of British Columbia, Canada.慢性灾难：探究加拿大不列颠哥伦比亚省人口中门诊处方药支出的集中性和持续性特征
Soc Sci Med. 2009 Mar;68(5):919-24. doi: 10.1016/j.socscimed.2008.12.008. Epub 2009 Jan 8.
Zotero 插件